Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology

Journal of the American College of Cardiology

Volumn 25, Issue 2, 1995, Pages 521-547

  Ritchie, James L ^a   Bateman, Timothy M ^a   Bonow, Robert O ^a   Crawford, Michael H ^a   Gibbons, Raymond J ^a   Hall, Robert J ^a   O'Rourke, Robert A ^a   Parisi, Alfred F ^a   Verani, Mario S ^a   Cheitlin, Melvin D ^a   Garson Jr , Arthur ^a   Lewis, Richard P ^a   Ryan, Thomas J ^a   Schlant, Robert C ^a   Winters Jr , William L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CARBON 11; DIPYRIDAMOLE; DOBUTAMINE; FLUORINE 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; PERTECHNETIC ACID TC 99M; PYROPHOSPHATE TECHNETIUM TC 99M; RADIOISOTOPE; RUBIDIUM 82; THALLIUM 201;

ACUTE HEART INFARCTION; CONGENITAL HEART DISEASE; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALVULAR HEART DISEASE;

ADULT; CORONARY DISEASE; HEART; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMAN; RADIONUCLIDE ANGIOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0028877697     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)90027-6     Document Type: Article

References (274)

1. Guidelines for Clinical Use of Cardiac Radionuclide Imaging December 1986 A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures
2. The Cardiovascular Imaging Committee American College of Cardiology Standardization of Cardiac Tomographic Imaging
3. Improved detection of myocardial infarction with technetium-99m stannous pyrophosphate and serum MB creatine phosphokinase
4. 99m-Tc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay
5. Early positive technetium-99m stannous pyrophosphate images as a marker of rerfusion after thrombolytic therapy for acute myocardial infarction
6. Myocardial scintigraphy with technetium-99m stannous pyrophosphate an insensitive test for nontransmural myocardial infarction
7. Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial
8. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody
9. Sequential radionuclide assessment of left and right ventricular performance after acute transmural myocardial infarction
10. Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiagrams with technetium-99m-sestamibi
11. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Comparison of unconscious and conscious dog models
12. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients
13. 99m-Tc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
14. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis-2-methoxyisobutyl isonitrile
15. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile
16. Effect of infarct location on myocardial salvage assessed by technetium-99m isonitrile
17. Primary angioplasty in myocardial infarction: assessment of improved myocardial perfusion with technetium-99m isonitrile
18. Risk stratification and survival after myocardial infarction
19. The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction
20. Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: identification of myocardial stunning and hyperkinesia
21. Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
22. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials
23. Relative prognostic value of rest thallium-201 imaging, radionuclide ventriculography and 24-hour ambulatory electrocardiographic monitoring after acute myocardial infarction
24. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction efficacy for noninvasive assessment of thrombolytic therapy
25. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography
26. From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy
27. The Thrombolysis in Myocardial Infarction (TIMI) trial
28. Interpreting results of exercise studies after acute myocardial infarction altered by thrombolytic therapy, coronary angioplasty or bypass
29. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study
30. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block dipyridamole
31. Diagnostic accuracy of exercise thallium-201 single-photon emission computed tomography in patients with left bundle branch block
32. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac event after acute myocardial infarction
33. Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging
34. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events
35. 201Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction
36. Serial tomographic imaging with technetium-99m-sestamibi for the assessment of infarct-related arterial patency following reperfusion therapy
37. Sequential teboroxime during and after balloon occlusion of a coronary artery
38. Determinants of infarct size in reperfusion therapy for acute myocardial infarction
39. Thallium-201 scintigraphy in unstable angina pectoris
40. Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery
41. Technetium-99m sestamibi tomography in patients with spontaneous chest pain: correlations with clinical, electrocardiographic and angiographic findings
42. Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi)
43. Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease
44. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment
45. Comparison of planar and tomographic exercise thallium-201 imaging methods for the evaluation of coronary artery disease
46. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease and comparison with coronary arteriography and exercise thallium-201 SPECT imaging
47. Myocardial perfusion imaging with Tc-99m-methoxy-isobutyl-isonitrile (MIBI): comparison of short and long time intervals between rest and stress injections
48. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease
49. Quantitative rotational tomography with Tl-201 and Tc-99m 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease
50. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging
51. Planar imaging techniques used with technetium-99m sestamibi to evaluate chronic myocardial ischemia
52. Technetium-99m sestamibi myocardial perfusion imaging for evaluation of coronary artery disease
53. Thallium-201 and technetium-99m perfusion agents: where we are in 1992
54. Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis
55. Stress scintigraphy using single-photon emission computed tomography in the evaluation of coronary artery disease
56. Sensitivity and specificity of thallium-201 perfusion scintigrams under exercise in the diagnosis of coronary artery disease
57. Exercise radionuclide imaging approaches to coronary artery disease
58. Should exercise electrocardiographic testing be replaced by radioisotope methods?
59. Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram
60. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?
61. Spatial and temporal quantitation of plane thallium myocardial images
62. “Circumferential profiles”: A new method for computer analysis of thallium-201 myocardial perfusion images
63. Space/time quantitation of thallium-201 myocardial scintigraphy
64. Quantitative planar thallium-201 stress scintigraphy: a critical evaluation of the method
65. Determination of the quantitative thallium imaging variables that optimize detection of coronary artery disease
66. Nuclear Cardiology
67. Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201
68. Tomographic myocardial perfusion imaging
69. Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease
70. Regional distribution of myocardial blood flow measured by single-photon emission tomography: comparison with in vitro counting
71. Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis for evaluation of coronary artery disease
72. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease
73. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients
74. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: optimization and prospective validation of a new technique
75. Quantitative exercise thallium-201 single-photon emission computed tomography for the enhanced diagnosis of ischemic heart disease
76. Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial
77. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods
78. Diagnostic value of a new myocardial perfusion agent, teboroxime (SQ 30,217) utilizing a rapid planar imaging protocol: preliminary results
79. Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging
80. Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy
81. Myocardial perfusion imaging with technetium-99m-labeled agents
82. Clinical comparison of technetium-99m-teboroxime and thallium-201 utilizing a continuous SPECT imaging protocol
83. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography
84. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82
85. Changes in myocardial perfusion reserve after PTCA: noninvasive assessment with positron tomography
86. Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography
87. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging
88. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 195 patients
89. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease
90. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease
91. Detection of coronary artery disease with positron emission tomography and rubidium-82
92. Cardiac positron emission tomography: a report for health professionals from the Committee and Advanced Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association
93. Thallium-201 myocardial imaging during maximal and submaximal exercise: comparison of submaximal exercise with propranolol
94. Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging
95. Beta-blockers and the sensitivity of the thallium treadmill test
96. Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina
97. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography
98. Effect of the degree of effort on the sensitivity of the exercise thallium-201 stress test in symptomatic coronary artery disease
99. Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease
100. Comparison of exercise perfusion and ventricular function imaging: an analysis of factors affecting the diagnostic accuracy of each technique
101. Thallium-201 exercise scintigraphy and left bundle branch block
102. Thallium-201 scintigraphy in complete left bundle branch block
103. Thallium-201 SPECT in coronary artery disease patients with left bundle branch block
104. Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole
105. Intravenous dipyridamole thallium-201 SPECT imaging in patients with left bundle branch block
106. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block
107. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. I. Physiologic basis and experimental validation
108. Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. II. Clinical methodology and feasibility
109. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. III. Clinical trial
110. Dipyridamole-thallium imaging: the lazy man's stress test
111. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise
112. Single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography
113. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease
114. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging
115. Effect of intravenous adenosine infusion on myocardial perfusion and function. Hemodynamic/angiographic and scintigraphic study
116. Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial
117. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease
118. Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease
119. Dobutamine thallium myocardial perfusion tomography
120. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion comparison of dobutamine and adenosine using echocardiography and Tc-99-m MIBI single photon emission computed tomography
121. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing
122. Pharmacologic stress myocardial perfusion imaging
123. Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease
124. Usefulness of technetium-99m-MIBI and thallium-201 in tomographic imaging combined with high-dose dipyridamole and handgrip exercise for detecting coronary artery disease
125. Accuracy and safety of technetium-99m hexakis 2-methoxy-2 isobutyl isonitrile (sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study
126. Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function
127. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catherization variables
128. Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers
129. Silent ischemia: evaluation by exercise and redistribution tomographic thallium-201 myocardial imaging
130. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography
131. Preoperative cardiac risk assessment for patients having peripheral vascular surgery
132. Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging
133. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery
134. Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium
135. Preoperative prediction of reversible myocardial asynergy by post-exercise radionuclide ventriculography
136. Nitroglycerin to unmask reversible asynergy: Correlation with post coronary bypass ventriculography
137. Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure
138. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy
139. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability
140. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging
141. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting
142. Quantitative planar rest-redistribution 201TI imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function
143. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium
144. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201
145. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m methoxyisobutyl isonitrile
146. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability
147. Positron emission tomography detects evidence of viability in rest technitium-99m sestamibi defects
148. 18F-fluorodeoxyglucose
149. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with thallium-201 and technetium-99m sestamibi
150. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
151. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting
152. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty
153. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
154. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
155. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism
156. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography
157. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue Rubidium-82 for assessing infarct size in man by PET
158. Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction
159. PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT
160. 18F-fluorodeoxyglucose
161. Metabolic activity in the areas of new fill-in after thailium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose
162. 201Tl defects
163. Survival in medically treated coronary artery disease
164. Survival of medically treated patients in the coronary artery surgery study (CASS) registry
165. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
166. The role of radionuclide angiocardiography in the preoperative prediction of pain relief and prolonged survival following coronary artery bypass grafting
167. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease
168. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catherization variables
169. Relation between exertional ischemia and prognosis in mildly symptomatic patients with single or double vessel coronary artery disease and left ventricular dysfunction at rest
170. Risk stratification of single or double vessel coronary artery disease and impaired left ventricular function using exercise radionuclide angiography
171. Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy
172. Prognostic valve and limitations of exercise radionuclide angiography in meically treated coronary artery disease
173. Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographic implications in patients with coronary artery disease
174. Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy
175. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease
176. Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis
177. Comparison of planar and tomographic exercise thallium-201 imaging methods for the evaluation of coronary artery disease
178. Comparison of technetium-99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods
179. Noninvasive identification of left main and triple vessel coronary artery disease: improved accuracy using quantitative analysis of region myocardial stress distribution and wash-out of thallium-201
180. Exercise thallium-201 myocardial imaging in left main coronary artery disease: sensitive but not specific
181. Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: comparison with patients with multiple- and single-vessel coronary artery disease
182. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging
183. Identification of high-risk patients with left main and three-vessel coronary artery disease using stepwise discriminant analysis of clinical, exercise, and tomographic thallium data
184. Assessment of jeopardized myocardium in patients with one-vessel disease
185. Relation between myocardial thallium-201 kinetics during exercise and quantitative coronary angiography in patients with one vessel coronary artery disease
186. The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography
187. Quantitative severity of stress thallium-201 myocardial perfusion single-photon emission computed tomography defects in one-vessel coronary artery disease
188. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?
189. Visual estimates of percent diameter coronary stenosis: a battered gold standard
190. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain
191. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease
192. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease
193. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary disease
194. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization
195. Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography
196. Prognostic value of atrial pacing and thallium-201 scintigraphy in patients with stable chest pain
197. Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease
198. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization
199. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease
200. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease
201. Exercise thallium-201 scintigraphy in men with nondiagnostic exercise electrocardiograms. Prognostic implications
202. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintinraphy and electrocardiography in asymptomatic volunteers
203. Prognostic implications of normal exercise thallium-201 images
204. Prognosis with chest pain and normal thallium-201 exercise scintigrams
205. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain
206. Prognostic implications of normal exercise thallium images
207. Exercise thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiography
208. Prognostic value of thallium-201 myocardial perfusion imaging
209. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging
210. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease
211. Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease
212. Thallium-201 myocardial imaging before and after coronary revascularization. Assessment of regional myocardial blood flow and graft patency
213. Thallium-201 myocardial perfusion imaging in the evaluation of saphenous aortocoronary bypass graft surgery
214. Thallium-201 exercise myocardial imaging to evaluate myocardial perfusion after coronary artery bypass surgery
215. Usefulness of tomographic thallium-201 imaging for detection of restenosis after percutaneous transluminal coronary angioplasty
216. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients
217. Short and long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy
218. Quantitative analysis of thallium-201 uptake and washout before and after transluminal coronary angioplasty
219. Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty
220. Predicting late restenosis after coronary angioplasty by very early (12 to 24 h) thallium-201 scintigraphy: implications with regard to mechanisms of late coronary restenosis
221. Early thallium imaging after percutaneous transluminal coronary angioplasty: tomographic evaluation during adenosine-induced coronary hyperemia
222. Improved myocardial function during exercise after successful percutaneous transluminal coronary angioplasty
223. Usefulness of early radionuclide angiography for identifying low-risk patients for late restenosis after percutaneous transluminal coronary angioplasty
224. Prevalence and prognostic significance of silent and symptomatic ischemia after coronary bypass surgery: a report from the Coronary Artery Surgery (CASS) randomized population
225. Accuracy of treadmill testing in assessment of direct myocardial revascularization
226. Thallium-201 myocardial imaging before and after coronary revascularization: assessment of regional myocardial blood flow and graft patency
227. Thallium-201 myocardial perfusion scintigrams in the evaluation of aortocoronary saphenous bypass surgery
228. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis
229. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis
230. Thallium-201 imaging and gated blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy. A clinical and pathologic study
231. Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: comparison of idiopathic dilated cardiomyopathy and coronary artery disease
232. Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography
233. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography
234. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography
235. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy Seven year experience using serial radionuclide angiography
236. Hypertrophic cardiomyopathy. Evaluation by gated cardiac blood pool scanning
237. Effects of verapamil and left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy
238. Idiopathic hypertrophic subaortic stenosis: detection by thallium 201 myocardial perfusion imaging
239. Myocardial perfusion abnormalities assessed by thallium-201 emission computed tomography in patients with hypertrophic cardiomyopathy
240. Myocardial ischemia is a frequent cause of cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy
241. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy
242. Radionuclide imaging in myocardial sarcoidosis. Demonstration of myocardial uptake of technetium pyrophosphate-99m and gallium
243. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma
244. Radionuclide detection, localization, and quantification of intracardiac shunts between the great arteries
245. Abnormal left ventricular filling: an early finding in mind to moderate systemic hypertension
246. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension: diastolic mechanisms for systolic dysfunction during exercise
247. Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain
248. Left ventricular systolic response to exercise in patients with systemic hypertension without left ventricular hypertrophy
249. The Registry of the International Society for Heart and Lung Transplantation: eighth official report–1991
250. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography
251. The clinical utility of radionuclide ventriculography in cardiac transplantation
252. Changes in left ventricular systolic function that accompany rejection of the transplanted heart: a serial radionuclide assessment of fifty-three consecutive cases
253. Detection of cardiac aliograft rejection using radionuclide techniques
254. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging
255. The role of indium-III antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection
256. Indium-III antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection
257. Indium-III-monoclonal antimyosin antibody studies after the first year of heart transplantation: Identification of risk groups for developing rejection during long-term follow-up and clinical implications
258. Gallium-67 imaging in human heart transplantation: correlation with endomyocardial biopsy
259. Thallium-201 myocardial imaging in patients with previous cardiac transplantation
260. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant
261. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium-99 in sestamibi
262. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography
263. Four radionuclide methods for left ventricular volume determination: comparison of a manual and an automated technique
264. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement
265. Quantification of valve regurgitation by radionuclide angiography before and after valve replacement surgery
266. Quantification of mitral insufficiency by radionuclide techniques
267. Early changes in left ventricular size and function after correction of left ventricular volume overload
268. Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients
269. Assessment of left ventricular and aortic valve function after aortic balloon valvuloplasty in adult patients with critical aortic stenosis
270. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function
271. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation
272. Long-term vasodilator therapy of chronic aortic insufficiency: a randomized double-blinded placebo-controlled clinical trial